PRMT5 Maintains Tumor Stem Cells to Promote Pediatric High-Grade Glioma Tumorigenesis
John DeSisto(Morgan Adams Foundation), Adam L. Green(Morgan Adams Foundation)
Cited by 2
Related Papers
NF-κB upregulation through epigenetic silencing of LDOC1 drives tumor biology and specific immunophenotype in Group A ependymoma
|Neuro-Oncology|2017|23
Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabine
|Journal of Neuro-Oncology|2020|18
PRMT5 maintains tumor stem cells to promote pediatric high-grade glioma tumorigenesis
|bioRxiv (Cold Spring Harbor Laboratory)|2024|0